Australia Plans Accelerated Approvals
TGA Proposes Fee Waivers And Faster Generic Registrations To Tackle Shortages
Executive Summary
Australia’s Therapeutic Goods Administration has proposed a range of mechanisms to reduce regulatory burden on companies with the explicit aim of addressing medicines shortages.
You may also be interested in...
Lupin Acquires Australia’s Southern Cross
Lupin has broadened its reach in Australia after agreeing a deal to buy local generics developer and distributor Southern Cross.
Global Medtech Guidance Tracker: September 2022
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-two documents have been posted on the tracker since its last update.
€5m Initiative To Help EU Member States Cooperate On Trial Safety Assessments
An EU funded project is to help national competent authorities cooperate on the safety assessment of clinical trials as required under the Clinical Trial Regulation.